Bioceres Crop Solutions Corp. - (BIOX) closed at $0.20 on November 16, 2026, down 4.9% from the previous close, on volume of 182,719 shares (30-day average 206,264).
Data as of November 16, 2026.
16-Nov-2026
No headlines found.
Bioceres Crop Solutions Reports Fiscal First Quarter 2027 Financial and Operational Results
Business Wire (Wed, 11-Nov 5:51 PM ET)
Business Wire (Mon, 14-Sep 6:44 PM ET)
Bioceres Crop Solutions Corp develops and commercializes productivity solutions designed to improve crop performance and support more sustainable agricultural practices. It has a broad biotech platform with high-impact, licensed and patented technologies for seeds and microbial ag-inputs, as well as biological and next-generation conventional crop nutrition and protection solutions. Its segments include crop protection consisting of Adjuvants and Pest control molecules; Seed and Integrated products consisting of Seed treatment packs, Seed traits, and Seed germplasm; and Crop Nutrition consisting of microbead fertilizers, Inoculants, Biofertilizers, and Crop health products and biostimulants. It derives the maximum revenue from the crop protection segment.
Bioceres Crop Solutions Corp. - trades on the NASDAQ stock market under the symbol BIOX.
As of November 16, 2026, BIOX stock price declined to $0.20 with 182,719 million shares trading.
BIOX has a beta of 2.08, meaning it tends to be more sensitive to market movements. BIOX has a correlation of 0.08 to the broad based SPY ETF.
BIOX has a market cap of $12.07 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BIOX traded as high as $14.05 and as low as $.19.
The top ETF exchange traded funds that BIOX belongs to (by Net Assets): ARGT.
BIOX has underperformed the market in the last year with a price return of -88.3% while the SPY ETF gained +11.2%. BIOX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -53.6% and -4.0%, respectively, while the SPY returned -4.6% and -2.1%, respectively.
BIOX support price is $.19 and resistance is $.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOX shares will trade within this expected range on the day.